Key facts
- This page summarizes Jonathan Anderman's Form 3 filing for Compass Therapeutics, Inc. (CMPX).
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 09 Aug 2024, 16:07.
Jonathan Anderman - 01 Aug 2024 Form 3 Insider Report for Compass Therapeutics, Inc. (CMPX)
- Reporting relationship
- Sr VP, Gen Counsel & Corp Sec
- Issuer ticker
- CMPX
- Reported as of
- 01 Aug 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 09 Aug 2024, 16:07:16 UTC
- Next SEC filing
- 14 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Neil Lerner, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jonathan Anderman filed Form 3 for Compass Therapeutics, Inc. (CMPX) on 09 Aug 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CMPX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,000
- Date
- 01 Aug 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CMPX
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 130,000
- Exercise price
- $4.05
- Footnotes
- F1
CMPX
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 85,000
- Exercise price
- $3.83
- Footnotes
- F2
CMPX
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $2.40
- Footnotes
- F3
CMPX
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 80,000
- Exercise price
- $3.93
- Footnotes
- F4
CMPX
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 80,000
- Exercise price
- $1.57
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
The options vest as follows: 25% on August 30, 2022, with the remaining over 36 substantially equal monthly installments starting September 30, 2022.
Footnote F2
The options vest over 48 substantially equal monthly installments starting December 16, 2021.
Footnote F3
The options vest over 48 substantially equal monthly installments starting March 18, 2022.
Footnote F4
The options vest over 48 substantially equal monthly installments starting March 8, 2023.
Footnote F5
The options vest over 48 substantially equal monthly installments starting March 9, 2024.
SEC remarks
Exhibit 24 - Power of Attorney